Virtus ETF Advisers LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$262,926
-13.8%
3,762
-11.4%
0.16%
-11.6%
Q2 2023$305,189
+28.2%
4,247
+10.0%
0.18%
+38.2%
Q1 2023$238,085
-18.7%
3,860
+1.7%
0.13%
-14.4%
Q4 2022$292,708
-37.1%
3,795
-63.6%
0.15%
-17.3%
Q3 2022$465,000
+18.3%
10,413
+1.5%
0.18%
+26.7%
Q2 2022$393,000
+88.0%
10,259
+103.0%
0.15%
+55.3%
Q1 2022$209,000
+3.5%
5,053
-5.6%
0.09%
+23.7%
Q4 2021$202,000
+94.2%
5,350
+70.1%
0.08%
+65.2%
Q3 2021$104,000
-53.4%
3,146
-5.0%
0.05%
-50.0%
Q2 2021$223,000
+4.7%
3,313
-11.8%
0.09%
+2.2%
Q1 2021$213,000
-29.2%
3,758
+1.8%
0.09%
-28.0%
Q4 2020$301,000
-1.0%
3,690
-13.6%
0.12%
-21.4%
Q3 2020$304,000
-23.6%
4,269
-11.8%
0.16%
-15.4%
Q2 2020$398,000
-11.9%
4,839
-37.1%
0.19%
+1.1%
Q1 2020$452,000
-50.3%
7,688
-12.6%
0.19%
+24.8%
Q4 2019$910,000
+306.2%
8,801
-20.5%
0.15%
+231.1%
Q3 2019$224,000
-25.6%
11,076
-5.3%
0.04%
-28.6%
Q2 2019$301,00011,6920.06%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders